Position in AZN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$502,872
New position
Shares Held
2,652
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#852
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Archford Capital Strategies, LLC holds $29,267,302 across 10 Drug Manufacturers - General names. AZN ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,636 | $10,320,324 | |
| 2 | NVS |
Novartis AG
|
49,908 | $7,821,581 | |
| 3 | MRK |
Merck & Co., Inc.
|
27,354 | $3,514,989 | |
| 4 | LLY |
ELI LILLY & Co
|
2,586 | $3,101,726 | |
| 5 | ABBV |
AbbVie Inc.
|
6,013 | $1,513,111 | |
| 6 | SNY |
Sanofi
|
33,227 | $1,417,463 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
2,652 | $502,872 | |
| 8 | PFE |
Pfizer Inc
|
18,376 | $442,494 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $502,872 | 2,652 | Shares | Sole | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||